CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced that the United States Food and Drug Administration has removed the partial clinical hold on the Company's aldoxorubicin clinical trials.
from The Medical News http://ift.tt/1BynCAu
from The Medical News http://ift.tt/1BynCAu
No comments:
Post a Comment